Gastroenterology
Volume 141, Issue 5 , Pages 1555-1559 , November 2011

Bugs, Stool, and the Irritable Bowel Syndrome: Too Much Is as Bad as Too Little?

  • Anthony A. Fodor

      Affiliations

    • Corresponding Author InformationReprint requests Address requests for reprints to: Anthony A. Fodor, Bioinformatics and Genomics Department, The University of North Carolina at Charlotte, 9201 University City Blvd, Charlotte, NC, 28223

References 

  1. Talley NJ , Spiller R . Irritable bowel syndrome: a little understood organic bowel disease? . Lancet . 2002;360:555–564
  2. Rey E , Talley NJ . Irritable bowel syndrome: novel views on the epidemiology and potential risk factors . Dig Liver Dis . 2009;41:772–780
  3. Koloski NA , Talley NJ , Boyce PM . The impact of functional gastrointestinal disorders on quality of life . Am J Gastroenterol . 2000;95:67–71
  4. Brandt LJ CW , Foxx-Orenstein AE , Schiller LR , et al.   An evidence-based position statement on the management of irritable bowel syndrome . Am J Gastroenterol . 2009;104:S1–S35
  5. Ford AC , Talley NJ , Veldhuyzen van Zanten SJO , et al.   Will the history and physical examination help establish that irritable bowel syndrome is causing this patient's lower gastrointestinal tract symptoms? . JAMA . 2008;300:1793–1805
  6. Villani A-C , Lemire M , Thabane M , et al.   Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis . Gastroenterology . 2010;138:1502–1513
  7. Choung RS , Locke GR , Zinsmeister AR , et al.   Psychosocial distress and somatic symptoms in community subjects with irritable bowel syndrome: a psychological component is the rule . Am J Gastroenterol . 2009;104:1772–1779
  8. Ford A , Talley N . Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review . J Gastroenterol . 2011;46:421–431
  9. Walker M , Warwick A , Ung C , et al.   The role of eosinophils and mast cells in intestinal functional disease . Curr Gastroenterol Rep . 2011;13:323–330
  10. Cremon C , Carini G , Wang B , et al.   Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome . Am J Gastroenterol . 2011;106:1290–1298
  11. Liebregts T , Adam B , Bredack C , et al.   Immune activation in patients with irritable bowel syndrome . Gastroenterology . 2007;132:913–920
  12. Spiller R , Garsed K . Postinfectious irritable bowel syndrome . Gastroenterology . 2009;136:1979–1988
  13. Sekirov I , Finlay BB . Human and microbe: united we stand . Nat Med . 2006;12:736–737
  14. Turnbaugh PJ , Hamady M , Yatsunenko T , et al.   A core gut microbiome in obese and lean twins . Nature . 2009;457:480–484
  15. Spencer MD , Hamp TJ , Reid RW , et al.   Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency . Gastroenterology . 2011;140:976–986
  16. Salonen A , de Vos WM , Palva A . Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives . Microbiology . 2010;156:3205–3215
  17. Saulnier D , Riehle K , Mistretta T , et al.   Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome . Gastroenterology . 2011;141:1782–1791
  18. Rajilić-Stojanović M , Biagi E , Heilig HG , et al.   Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome . Gastroenterology . 2011;141:1792–1801
  19. Carroll IM , Ringel-Kulka T , Keku TO , et al.   Molecular analysis of the luminal and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome . Am J Physiol Gastrointest Liver Physiol . 2011 July 7; [Epub ahead of print]
  20. Adam B , Liebregts T , Gschossmann JM , et al.   Severity of mucosal inflammation as a predictor for alterations of visceral sensory function in a rat model . Pain . 2006;123:179–186
  21. Leek JT , Scharpf RB , Bravo HC , et al.   Tackling the widespread and critical impact of batch effects in high-throughput data . Nat Rev Genet . 2010;11:733–739
  22. Zhou J , Wu L , Deng Y , et al.   Reproducibility and quantitation of amplicon sequencing-based detection . ISME J . 2011;5:1303–1313
  23. Boulesteix A-L . Over-optimism in bioinformatics research . Bioinformatics . 2010;26:437–439
  24. Moayyedi P , Ford AC , Talley NJ , et al.   The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review . Gut . 2010;59:325–332
  25. Brenner DM , Moeller MJ , Chey WD , et al.   The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review . Am J Gastroenterol . 2009;104:1033–1049
  26. Pimentel M , Lembo A , Chey WD , et al.   Rifaximin therapy for patients with Irritable Bowel Syndrome without constipation . N Engl J Med . 2011;364:22–32
  27. Mendall MA KD . Antibiotic use, childhood affluence and irritable bowel syndrome . Eur J Gastroenterol Hepatol . 1998;10:59–62

 Conflicts of Interest NJT has consulted for Salix. The remaining author discloses no conflicts.

PII: S0016-5085(11)01254-6

doi: 10.1053/j.gastro.2011.09.019

Gastroenterology
Volume 141, Issue 5 , Pages 1555-1559 , November 2011

Article Tools

* Image Usage & Resolution